Fuad Iraqi, PhD, Israel

Prof. Iraqi is a molecular geneticist and world leader in the area of understanding diseases etiology and dissecting complex traits including hosts susceptibility to infection and chronic diseases, including Klebsiella pneumonia, Aspergillus fumigatus, dental infection (Periodontitis), Type 2 Diabetes and cardiovascular diseases (CVD) associated with Obesity, gut and oral microbiota and mapping modifiers for colon cancer development. Furthermore, he has ongoing projects for identifying the host genetic factors/background Influencing the efficiency of Drug treatments for type 2 diabetes (T2D), which is definedas Pharmacogenetics studies. His research projects are important for better understanding the host susceptibility to variety of infectious, chronic diseases, and drug treatments, which will serve a step towards improving our knowledge of specific and general pathways and network systems, which can lead to establish a better/early disease detection, which subsequently will lead to implement powerful prevention and control and design strategies.